Zydus Lifesciences Statistics
Total Valuation
NSE:ZYDUSLIFE has a market cap or net worth of INR 980.07 billion. The enterprise value is 980.33 billion.
Market Cap | 980.07B |
Enterprise Value | 980.33B |
Important Dates
The last earnings date was Tuesday, February 4, 2025.
Earnings Date | Feb 4, 2025 |
Ex-Dividend Date | Jul 26, 2024 |
Share Statistics
NSE:ZYDUSLIFE has 1.01 billion shares outstanding. The number of shares has decreased by -0.31% in one year.
Current Share Class | n/a |
Shares Outstanding | 1.01B |
Shares Change (YoY) | -0.31% |
Shares Change (QoQ) | -0.06% |
Owned by Insiders (%) | 75.08% |
Owned by Institutions (%) | 13.65% |
Float | 249.07M |
Valuation Ratios
The trailing PE ratio is 22.97 and the forward PE ratio is 21.54. NSE:ZYDUSLIFE's PEG ratio is 3.17.
PE Ratio | 22.97 |
Forward PE | 21.54 |
PS Ratio | 4.57 |
PB Ratio | 4.49 |
P/TBV Ratio | 7.19 |
P/FCF Ratio | 30.84 |
P/OCF Ratio | n/a |
PEG Ratio | 3.17 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.52, with an EV/FCF ratio of 30.84.
EV / Earnings | 22.78 |
EV / Sales | 4.56 |
EV / EBITDA | 15.52 |
EV / EBIT | 17.83 |
EV / FCF | 30.84 |
Financial Position
The company has a current ratio of 2.27, with a Debt / Equity ratio of 0.01.
Current Ratio | 2.27 |
Quick Ratio | 1.34 |
Debt / Equity | 0.01 |
Debt / EBITDA | 0.03 |
Debt / FCF | 0.06 |
Interest Coverage | 72.26 |
Financial Efficiency
Return on equity (ROE) is 19.57% and return on invested capital (ROIC) is 14.80%.
Return on Equity (ROE) | 19.57% |
Return on Assets (ROA) | 11.74% |
Return on Invested Capital (ROIC) | 14.80% |
Return on Capital Employed (ROCE) | 20.63% |
Revenue Per Employee | 7.98M |
Profits Per Employee | 1.60M |
Employee Count | 26,921 |
Asset Turnover | 0.75 |
Inventory Turnover | 1.80 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +26.48% in the last 52 weeks. The beta is 0.48, so NSE:ZYDUSLIFE's price volatility has been lower than the market average.
Beta (5Y) | 0.48 |
52-Week Price Change | +26.48% |
50-Day Moving Average | 974.14 |
200-Day Moving Average | 1,054.25 |
Relative Strength Index (RSI) | 51.14 |
Average Volume (20 Days) | 1,016,636 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:ZYDUSLIFE had revenue of INR 214.84 billion and earned 43.03 billion in profits. Earnings per share was 42.65.
Revenue | 214.84B |
Gross Profit | 151.81B |
Operating Income | 53.83B |
Pretax Income | 57.58B |
Net Income | 43.03B |
EBITDA | 61.86B |
EBIT | 53.83B |
Earnings Per Share (EPS) | 42.65 |
Balance Sheet
The company has 24.95 billion in cash and 1.91 billion in debt, giving a net cash position of 23.05 billion or 22.90 per share.
Cash & Cash Equivalents | 24.95B |
Total Debt | 1.91B |
Net Cash | 23.05B |
Net Cash Per Share | 22.90 |
Equity (Book Value) | 241.55B |
Book Value Per Share | 217.00 |
Working Capital | 68.06B |
Cash Flow
In the last 12 months, operating cash flow was 45.94 billion and capital expenditures -14.16 billion, giving a free cash flow of 31.78 billion.
Operating Cash Flow | 45.94B |
Capital Expenditures | -14.16B |
Free Cash Flow | 31.78B |
FCF Per Share | 31.59 |
Margins
Gross margin is 70.66%, with operating and profit margins of 25.06% and 20.03%.
Gross Margin | 70.66% |
Operating Margin | 25.06% |
Pretax Margin | 26.80% |
Profit Margin | 20.03% |
EBITDA Margin | 28.79% |
EBIT Margin | 25.06% |
FCF Margin | 14.79% |
Dividends & Yields
This stock pays an annual dividend of 3.00, which amounts to a dividend yield of 0.31%.
Dividend Per Share | 3.00 |
Dividend Yield | 0.31% |
Dividend Growth (YoY) | -50.00% |
Years of Dividend Growth | n/a |
Payout Ratio | 7.05% |
Buyback Yield | 0.31% |
Shareholder Yield | 0.62% |
Earnings Yield | 4.39% |
FCF Yield | 3.24% |
Stock Splits
The last stock split was on October 6, 2015. It was a forward split with a ratio of 5.
Last Split Date | Oct 6, 2015 |
Split Type | Forward |
Split Ratio | 5 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |